Money
-
Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year? | Smart Stocks News
Every second, thousands of people around the world open a can of Red Bull, Monster, Pepsi, or Coca-Cola. Few realise…
Read More » -
Centum Electronics: Why a Rs 52-crore loss hasn’t derailed the rally | Smart Stocks News
Centum Electronics ended FY26 with a reported net loss of nearly Rs 52 crore. On paper, that leaves the company…
Read More » -
Syngene International: Could India’s WuXi moment finally be here? | Smart Stocks News
There is a research campus in Bengaluru where scientists work on some of the most advanced challenges in modern medicine.…
Read More » -
WPIL’s Rs 6,000-cr order book is growing. Why isn’t the market convinced? | Smart Stocks News
In January 2025, shares of WPIL Ltd, the 73-year-old Kolkata-based pump manufacturer, traded around Rs 768. By March 2026, the…
Read More » -
Honasa Consumer is growing again, but can it keep margins intact? | Smart Stocks News
Honasa Consumer, the company behind Mamaearth, listed in late 2023. Soon after, growth slowed to single digits, operating profits collapsed,…
Read More » -
After a 38% rally, can VA Tech Wabag deliver more? | Smart Stocks News
Over the last two years, VA Tech Wabag’s revenue grew by nearly 20% annually, its operating margin roughly doubled over…
Read More » -
Can Supriya Life Sciences unlock its next leg of growth beyond APIs? | Smart Stocks News
There is an uncomfortable truth about the pharmaceutical ingredient industry. Most Active Pharmaceutical Ingredients (API) companies spend years building expertise,…
Read More » -
Gujarat Themis Biosyn’s Rs 3,000 crore bet: Can it build a global pharma platform? | Smart Stocks News
Two acquisitions — one from a French pharmaceutical giant and another from a 60-year-old Japanese Contract Development and Manufacturing Organization…
Read More » -
From scooter frames to satellite parts: Belrise’s quiet push into the global aerospace supply chain | Smart Stocks News
There is a factory in Aurangabad that, until a year ago, almost no stock-market investor had heard of. Belrise Industries…
Read More » -
Specialty chemicals, peptides, and pricing recovery: The Alkyl Amines opportunity | Smart Stocks News
Peptides are behind the world’s fastest-growing class of weight-loss drugs. Beyond weight loss, they are being developed for cancer, hormonal…
Read More »